Winson Tang MD worked as the Vice President of Drug Development at Isis Pharmaceuticals between July 2002 and March 2004. In this role he was responsible for the daily operations of the clinical operation, data management and biostatistics.
Winson Tang has extended professional experience in a wide variety of roles and functions. At Sangamo Bioscience, Inc., he was responsible for all clinical development programs. At Amsterdam Molecular Therapeutics, BV, he oversaw the design and conduct of various drug trials, including a Phase 2/3 Glybera orphan drug registrations process. He developed the product profile for the drug, among other tasks and activities.